Japan Approves VTAMA Cream for Pediatric Atopic Dermatitis

AI-generated NewsSnap summary based on source reporting.
Published: 2026-09-16
Category: health
Source: Shionogi Inc.
Original source

Shionogi & Co., Ltd. and Torii Pharmaceutical Co., Ltd. have secured manufacturing and marketing approval in Japan for VTAMA® Cream 0.5% (tapinarof) to treat atopic dermatitis in children under 12. This nonsteroidal, aryl hydrocarbon receptor modulating agent offers a new therapeutic option for pediatric patients suffering from the skin condition. The approval expands treatment choices for a common childhood ailment.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai